Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 170 | 202 | 141 | 135 | 163 |
| Cost of Goods | 31 | 42 | N/A | 850 | 806 |
| Gross Profit | 139 | 160 | 141 | -715 | -643 |
| Operating Expenses | 19,942 | 32,118 | 20,064 | 18,973 | 15,315 |
| Operating Income | -19,772 | -31,916 | -19,923 | -18,838 | -15,152 |
| Interest Expense | 585 | 0 | 0 | 67 | 672 |
| Other Income | 3,037 | 2,954 | 478 | -222 | 1,424 |
| Pre-tax Income | -17,320 | -28,962 | -19,445 | -19,127 | -14,400 |
| Net Income Continuous | -17,320 | -28,962 | -19,445 | -19,127 | -14,400 |
| Net Income | $-17,320 | $-28,962 | $-19,445 | $-19,127 | $-14,400 |
| EPS Basic Total Ops | -31.00 | -60.00 | -40.00 | -40.00 | -45.00 |
| EPS Basic Continuous Ops | -30.92 | -59.61 | -40.47 | -40.40 | -45.22 |
| EPS Diluted Total Ops | -31.00 | -60.00 | -40.00 | -40.00 | -45.00 |
| EPS Diluted Continuous Ops | -30.92 | -59.61 | -40.47 | -40.40 | -45.22 |
| EPS Diluted Before Non-Recurring Items | -31.00 | -60.00 | -40.00 | -40.00 | -45.00 |
| EBITDA(a) | $-19,177 | $-31,664 | $-19,667 | $-18,016 | $-14,149 |